UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.443

Sortiert nach

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Vaccine, 2020-07, Vol.38 (33), p.5119-5122

2020

Link zum Volltext

Verfügbarkeit prüfen

Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States

Human vaccines & immunotherapeutics, 2018-01, Vol.14 (8), p.2016-2024

2018

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Vaccine, 2013-11, Vol.31 (47), p.5500-5505

Osazuwa-Peters, N

2013

Link zum Volltext

Verfügbarkeit prüfen

Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13-17 by metropolitan statistical area (MSA) status, National Immunization Survey - Teen, 2013 - 2017

Human vaccines & immunotherapeutics, 2020-03, Vol.16 (3), p.554-561

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

Infectious agents and cancer, 2023-05, Vol.18 (1), p.29-29, Article 29

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trial

Human vaccines & immunotherapeutics, 2016-12, Vol.12 (12), p.3177-3185

2016

Link zum Volltext

Verfügbarkeit prüfen

Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019

Vaccine, 2022-03, Vol.40 (Suppl 1), p.A38-A48

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction

Vaccine, 2022-03, Vol.40, p.A26-A29

2022

Link zum Volltext

Verfügbarkeit prüfen

"You Don't Know If It's the Truth or a Lie": Exploring Human Papillomavirus (HPV) Vaccine Hesitancy among Communities with Low HPV Vaccine Uptake in Northern California

Vaccines (Basel), 2024-04, Vol.12 (4), p.372

2024

Link zum Volltext

Verfügbarkeit prüfen

CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8 + T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication

Frontiers in immunology, 2020-05, Vol.11, p.1012-1012

2020

Link zum Volltext

Verfügbarkeit prüfen

Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands

Vaccine, 2011-06, Vol.29 (28), p.4601-4607

2011

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India–2018–2019

Vaccine, 2022-03, Vol.40 (Suppl 1), p.A17-A25

2022

Link zum Volltext

Verfügbarkeit prüfen

Medical students' knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2344248-2344248

2024

Link zum Volltext

Verfügbarkeit prüfen

Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2313249-2313249

2024

Link zum Volltext

Verfügbarkeit prüfen

Assessing university students’ sexual risk behaviors as predictors of human papillomavirus (HPV) vaccine uptake behavior

Vaccine, 2018-06, Vol.36 (25), p.3629-3634

2018

Link zum Volltext

Verfügbarkeit prüfen

Early impact of Ontario’s human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment

Vaccine, 2016-09, Vol.34 (39), p.4678-4683

2016

Link zum Volltext

Verfügbarkeit prüfen

School Teachers' Perceptions of Adolescent Human Papillomavirus (HPV) Vaccination: A Systematic Review

Vaccines (Basel), 2024-04, Vol.12 (4), p.361

2024

Link zum Volltext

Verfügbarkeit prüfen

Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review

Vaccines (Basel), 2021-11, Vol.9 (11), p.1360

2021

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated with College Students' Human Papillomavirus (HPV) Vaccination and Preferred Strategies for Catch-Up Vaccine Promotion: A Mixed-Methods Study

Vaccines (Basel), 2023-06, Vol.11 (6), p.1124

2023

Link zum Volltext

Verfügbarkeit prüfen

Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review

Vaccines (Basel), 2021-05, Vol.9 (5), p.496

2021

Link zum Volltext

Verfügbarkeit prüfen

The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: A systematic review of observational studies in the United States

Vaccine, 2012-06, Vol.30 (31), p.4588-4595

2012

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus (HPV) insertional mutation as a dynamic & specific tumour biomarker in HPV-associated carcinoma

Indian journal of medical research (New Delhi, India : 1994), 2015-11, Vol.142 (5), p.507

Sastre-Garau, Xavier

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years

Human vaccines & immunotherapeutics, 2020-06, Vol.16 (6), p.1392-1403

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.443

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

PublikationsformReviews

ThemaMiddle Aged

KollektionIngenta

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.374)
Mit Volltextzugriff
(4.240)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(4.354)
Life Sciences & Biomedicine
(4.233)
Humans
(2.484)
Human Papillomavirus
(2.335)
Vaccines
(2.192)
Medicine, Research & Experimental
(2.176)
Research & Experimental Medicine
(2.176)
Female
(1.518)
Immunization
(1.327)
Vaccination
(1.281)
Cervical Cancer
(1.172)
Papillomavirus Infections - Prevention & Control
(871)
Allergy And Immunology
(818)
Infections
(800)
Cancer
(719)
Adolescent
(688)
Microbiology
(660)
Animals
(633)
Biotechnology & Applied Microbiology
(614)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccine
(1.441)
Vaccines
(645)
Human Vaccines & Immunotherapeutics
(585)
Infectious Agents And Cancer
(273)
Plos One
(112)
Frontiers In Immunology
(92)
Frontiers In Cellular And Infection Microbiology
(57)
Indian Journal Of Medical Research
(54)
Viral Immunology
(41)
Immunologic Research
(40)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(7)
... seit 90 Tagen
(47)

Menü

Weitere Dienste

Einstellungen

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13-17 by metropolitan statistical area (MSA) status, National Immunization Survey - Teen, 2013 - 2017

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trial

Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction

"You Don't Know If It's the Truth or a Lie": Exploring Human Papillomavirus (HPV) Vaccine Hesitancy among Communities with Low HPV Vaccine Uptake in Northern California

CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8 + T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication

Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands

Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India–2018–2019

Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021—March 2022

Medical students' knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer

Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years

Assessing university students’ sexual risk behaviors as predictors of human papillomavirus (HPV) vaccine uptake behavior

Early impact of Ontario’s human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9–14 years: Results to month 36 from a randomized trial

School Teachers' Perceptions of Adolescent Human Papillomavirus (HPV) Vaccination: A Systematic Review

Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review

Factors Associated with College Students' Human Papillomavirus (HPV) Vaccination and Preferred Strategies for Catch-Up Vaccine Promotion: A Mixed-Methods Study

Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review

The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: A systematic review of observational studies in the United States

Human papillomavirus (HPV) insertional mutation as a dynamic & specific tumour biomarker in HPV-associated carcinoma

Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years

Aktive Filter

Suchergebnisse filtern